Impact of molecular response time achievement on survival of chronic phase chronic myelogenous leukemia patients treated by imatinib.

Autor: Amrita, Putu Niken Ayu1, Bintoro, S. Ugroseno Yudho1 ugrosenoyb2004@yahoo.com
Zdroj: Drug Invention Today. Jun2020, Vol. 13 Issue 6, p863-867. 5p. 2 Charts, 1 Graph.
Databáze: Academic Search Ultimate